felix chem retatrutide Obesity and emerging intervention strategies: Mechanistic insights and novel drug targets Influencers are pushing suspicious peptides.

Is peptide dosage based on body weight

Retatrutide is an investigational once-weekly injectable peptide that simultaneously activates GLP-1, GIP, and glucagon receptors, distinguishing it from approved single or dual receptor agonists such as semaglutide and tirzepatide

Weight Loss Pills Weight loss injections, such as semaglutide and tirzepatide, work through hormone pathways that help regulate appetite, fullness, and blood sugar-related signals

It acts on GLP-1 and GIP receptors

doi: 10.1038/s41467-022-28683-0 127 KnerrPJMowerySADourosJDPremdjeeBHjllundKRHeYet al

No, Retatrutide is currently: Not licensed in the UK Not available through the NHS Not available privately Only accessible within approved clinical research trials Any websites or social media sellers claiming to supply Retatrutide injections are not legitimate and should be avoided , as unlicensed medicines may be unsafe